Page 3 - Medicines

Glenmark Pharma introduces generic eye treatment medication in US

Glenmark Pharmaceuticals on Monday said its US-based subsidiary has introduced a generic medication used for eye itching. Glenmark Therapeutics Inc, USA has launched Olopatadine Hydrochloride Ophthalmic Solution (OTC) in the US market, the Mumbai-based drug maker said in a regulatory filing. Fabio Moreno, Head of OTC Sales & Marketing, Glenmark Pharmaceuticals Inc, said the launch of Olopatadine Ophthalmic Solution (USP, 0.1 per cent), addresses a growing demand for a new supplier in this category. "This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers," Moreno said.

‘Allopathy medicines are poison’: Baba Ramdev lands into hot waters

In what could lead to fresh legal trouble, yoga guru Ramdev landed in a new controversy on Thursday after calling allopathy medicines “poisonous” and blaming them for “killing millions of people.

Govt plans regulatory crackdown on similar-sounding, look-alike drug brands

Drug manufacturers in India will soon be required to upload their product formulations and brand names on the government's portal

Online pharmacy players look for regulatory framework for industry

A division bench of the Madras HC has set aside an earlier order that disallowed them to engage in digital sale of medicines

Govt planning regulatory crackdown on look-alike, sound-alike drug names

In order to safeguard patients, the Drug Technical Advisory Board (DTAB) proposed banning the production and marketing of distinct drugs under identical brand names

AstraZeneca aims to grow its total revenue by 75% to $80 bn by 2030

The Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030

Doctors not mandated to inform patients on drug side effects: Delhi HC

Delhi High Court dismissed a public interest litigation that sought to enforce the compulsory disclosure of drug side effects by doctors to the patients

World Homeopathy Day 2024: All about Homoeopathy and its benefits

The target of homoeopathy is to address and to give therapy the whole of an individual, including their character, way of life, hereditary predispositions, and disease history

5 dead, over 100 hospitalised from recalled Japanese health supplements

Kobayashi Pharmaceutical Co. came under fire for not going public quickly with problems known internally as early as January

Misleading ads case: SC orders Ramdev, Balakrishna to appear in person

Patanjali Ayurved has faced scrutiny from the top court for disseminating misleading advertisements that claim to treat medical conditions, a violation of the Magic Remedies Act, 1954

Centre seeks more time to frame policy on online sale of medicines

The Centre has urged the Delhi High Court to grant some time to frame a policy on the online sale of medicines on the grounds that the issue was "complex" and any modification in the manner of sale of drugs would have far-reaching consequences. The high court granted the Union Ministry of Health and Family Welfare four months as a last and final opportunity to frame the policy. A bench of Acting Chief Justice Manmohan and Justice Manmeet PS Arora made clear that "if the draft policy is not prepared before the next date of hearing, this court will have no other option but to proceed ahead with the matter". The high court, which was hearing several petitions seeking a ban on the "illegal" sale of drugs online and challenging the draft rules published by the ministry to further amend the Drugs and Cosmetics Rules, listed the matter for further hearing on July 8. It had earlier asked the Centre to file a status report on the petitions. During the recent hearing, the joint secretary of

Govt revamps pharma scheme, to provide financial assistance to drug cos

Financial support for drug companies also comes against the backdrop of deaths being reported abroad due to the manufacture of substandard drugs linked to Indian companies

7 in 10 Indians opt for nutraceuticals; most don't consult doctors: Survey

The survey by LocalCircles also highlighted that 68 per cent of nutraceutical users buy them from local medical or general stores

India sends relief material including medicines to cholera-affected Zambia

India has sent relief material, including medicines, to Zambia to help it deal with an outbreak of cholera, External Affairs Minister S Jaishankar said on Saturday. He said India stands with Zambia in this "trying time". "India sends Humanitarian Assistance to Zambia in wake of the cholera outbreak," Jaishankar posted on X along with a photograph of relief material consignments. "The aid weighing approx 3.5 tons comprises water purification supplies, chlorine tablets and ORS sachets. Was handed over today by our High Commissioner to the Government of Zambia," he said.

TechEagle partners with 10 Aiims for fast medicine delivery via drones

Drone logistics company TechEagle on Monday said it has entered into collaborations with 10 AIIMS for the fast delivery of medicines. "TechEagle's nationwide impact is underscored by...collaborations with 10 AIIMS & INI's hospitals, swiftly implementing drone services and setting new range and speed records," the company said in a statement. In a significant trial, TechEagle transported a medical payload of up to five kilogram to rural primary health centres at AIIMS Rajkot and AIIMS Mangalagiri. "At TechEagle, we see a future where drones play a key role in solving India's healthcare challenges. The quick implementation of BVLOS (Beyond Visual Line of Sight) drone delivery services in 10 AIIMS & INI's hospitals underlines our commitment to improving healthcare logistics for our country with safety and reliability," TechEagle founder and CEO Vikram Singh Meena said. TechEagle had earlier said its drone transported essential tuberculosis medicine in just 34 minutes. During its .

Amended biological diversity law raises fear of loss for tribals

The mandated percentage of earnings that goes as ABS ranges from 0.1 to 0.5 per cent of sales, depending on the company's revenue, according to AYUSH industry estimates

DGHS asks pharmacists to dispense antibiotics only on doctor's prescription

DGHS Atul Goel appealed to all pharmacists to strictly implement Schedules H and H1 of the Drugs and Cosmetics Rules, 1945, with regards to selling antibiotics

Implementing revised Schedule M rules uphill task for small pharma

Analysts also feel this move will help improve quality of Indian drugs

ICRA predicts 9-11% growth in FY24 fuelled by new launches, US rebound

ICRA anticipates expansion in revenues for its sample set of 25 companies, which represent approximately 60 per cent of the overall revenues of the Indian pharmaceutical industry

Lupin expands global portfolio with acquisition of assets from Sanofi

The deal involves the acquisition of a portfolio of accretive established products in Europe and Canada